Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Micelles As Delivery System for Cancer Treatment
Date
2017-01-01
Author
Keskin, Dilek
Tezcaner, Ayşen
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
150
views
0
downloads
Cite This
Micelles are nanoparticles formed by the self-assembly of amphiphilic block copolymers in certain solvents above concentrations called critical micelle concentration (CMC). Micelles are used in different fields like food, cosmetics, medicine, etc. These nanosized delivery systems are under spotlight in the recent years with new achievements in terms of their in vivo stability, ability to protect entrapped drug, release kinetics, ease of cellular penetration and thereby increased therapeutic efficacy. Drug loaded micelles can be prepared by dialysis, oil-in-water method, solid dispersion, freezing, spray drying, etc. The aim of this review is to give an overview of the research on micelles (in vitro, in vivo and clinical) as delivery system for cancer treatment. Passive targeting is one route for accumulation of nanosized micellar drug formulations. Many research groups from both academia and industry focus on developing new strategies for improving the therapeutic efficacy of micellar systems (active targeting to the tumor site, designing multidrug delivery systems for overcoming multidrug resistance or micelles formed by prodrug conjugates, etc). There is only one micellar drug formulation in South Korea that has reached clinical practice. However, there are many untargeted anticancer drug loaded micellar formulations in clinical trials, which have potential for use in clinics. Many more products are expected to be on the market in the near future.
Subject Keywords
Critical micelle concentration (CMC)
,
Copolymers
,
Multi-drug delivery
,
Cancer therapy
,
Tumor targeted delivery
,
Micelles
URI
https://hdl.handle.net/11511/47035
Journal
CURRENT PHARMACEUTICAL DESIGN
DOI
https://doi.org/10.2174/1381612823666170526102757
Collections
Department of Engineering Sciences, Article
Suggestions
OpenMETU
Core
Controlled release of vancomycin from biodegradable microcapsules
Ozalp, Y; Ozdemir, N; Kocagoz, S; Hasırcı, Vasıf Nejat (2001-01-01)
Poly D,L-lactic acid (PLA) and its copolymers with glycolide PLGA 90:10 and 70:30 were polymerized under various conditions to yield polymers in the molecular weight range 12 000-40 000 daltons, as determined by gel permeation chromatography. Vancomycin hydrochloride was the hydrophilic drug of choice for the treatment of methicillin resistant Staphyloccoccal infections. It was microencapsulated in the synthesized polymers using water-oil-water (w/o/w) double emulsion and solvent evaporation. The influence ...
Distyryl-boradiazaindacenes: facile synthesis of novel near IR emitting fluorophores
Dost, Zeynep; Atilgan, Serdar; Akkaya, Engin U. (Elsevier BV, 2006-09-04)
Boradiazaindacenes with methyl substituents at 3 and 5 positions were for the first time shown to undergo efficient double condensation reactions with an aromatic aldehyde yielding a series of extended conjugation dyes. These new fluorophores have absorption maxima in the range of 650-660 nm. The dyes reported here have large quantum yields with 20 nm Stokes' shifted emission peaks. The straightforward synthesis of such red shifted BODIPY derivatives is important in relation to the synthesis of novel and us...
DFT investigation of high temperature water gas shift reaction on chromium-iron mixed oxide catalyst
Yalcin, Ozgen; Önal, Işık (2014-11-20)
As part of high temperature water gas shift reaction mechanism, CO adsorption and H2O adsorption on Fe3O4 (111) and chromium atom substituted Fe3O4 (111) slab surfaces are investigated by means of periodic DFT approach using VASP. Fe3O4 bulk structure has been computed including the Hubbard (U) parameter. One oxygen site (Ooct1) is studied as a probable site among the six Fe3O4 (111) terminations. Cr atom substitution on this surface is also examined. Cr atoms prefer being on the surface rather than in the ...
Novel conversion of thiols into disulfides, via S-nitrosothiol intermediates using trichloronitromethane
Demir, Ayhan Sıtkı; Igdir, AC; Mahasneh, AS (1999-10-15)
An efficient oxidative coupling of thiols to give disulfides via thionitrite (S-nitrosothiol) intermediate is described using trichloronitromethane as an efficient reagent in organic solvents and water. Cysteine and glutathione are converted into the corresponding disulfides in water in high yields.
Improvement in magnetic properties of La substituted BaFe12O19 particles prepared with an unusually low Fe/Ba molar ratio
Sozeri, H.; KÜÇÜK, İLKER; Ozkan, H. (2011-07-01)
In this study, effect of lanthanum substitution on the phase composition, lattice parameters and magnetic properties of barium hexaferrite has been studied in samples synthesized in ammonium nitrate melt. Samples, prepared with different lanthanum amount and having various initial Fe/(Ba + La) ratios in between 12 and 2 {(Ba1-xLax).n Fe2O3, where 0 <= x <= 1 and 1 <= n <= 6)}, are sintered at temperatures from 800 to 1200 degrees C. The lattice parameters, both a and c, decreases with increasing La amount w...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. Keskin and A. Tezcaner, “Micelles As Delivery System for Cancer Treatment,”
CURRENT PHARMACEUTICAL DESIGN
, pp. 5230–5241, 2017, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/47035.